GlaxoSmithkline Consumer Healthcare Ltd(Merged)
company logo

GlaxoSmithkline Consumer Healthcare Ltd(Merged)

GlaxoSmith C H L Share Price

FMCG
Small Cap

-

0 (0%)

Start Investing in GlaxoSmithkline Consumer Healthcare Ltd(Merged)

*By signing up you agree to our Terms and Conditions

GlaxoSmithkline Consumer Healthcare Ltd(Merged) Performance

-

-

-

-


-

-

-

-

-

GlaxoSmithkline Consumer Healthcare Ltd(Merged) Fundamentals

i buttonClick here to know more about Fundamentals

GlaxoSmithkline Consumer Healthcare Ltd(Merged) Financials

GlaxoSmithkline Consumer Healthcare Ltd(Merged) Financialsright-arrow

GlaxoSmithkline Consumer Healthcare Ltd(Merged) Shareholding Pattern

GlaxoSmithkline Consumer Healthcare Ltd(Merged) Delivery and Volume

About GlaxoSmithkline Consumer Healthcare Ltd(Merged)

GlaxoSmithKline Consumer Healthcare Ltd is one of the largest players in the Health Food Drinks industry in India. The company is an Indian associate of GlaxoSmithKline plc, UK, one of world's largest consumer healthcare companies. The company's principal activities are to manufacture and distribute

Navneet Saluja

1958

GSKCONS

NameDesignation
Kunal KashyapIndependent Director
Naresh DayalIndependent Director
P Dwarakanth Chairman
Sangeeta Talwar Independent Director
Shanu Saksena Company Secretary
Anup Dhingra Director (Operation)
Navneet Saluja Managing Director
S Madhavan Independent Director
Pradeep V Bhide Independent Director
News and Events...

Similar Stocks

What's Trending

View All
View All

GlaxoSmithkline Consumer Healthcare Ltd(Merged) FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase GlaxoSmithkline Consumer Healthcare Ltd(Merged) shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. GlaxoSmithkline Consumer Healthcare Ltd(Merged)'s share price is ₹10732.6 as of 2024-09-19.
GlaxoSmithkline Consumer Healthcare Ltd(Merged)'s P/E ratio is - times as of 2024-09-19.
GlaxoSmithkline Consumer Healthcare Ltd(Merged)'s most recent financial reports indicate a price-to-book ratio of -, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. GlaxoSmithkline Consumer Healthcare Ltd(Merged)'s market capitalization is ₹- Cr as on 2024-09-19.
The current financial records of GlaxoSmithkline Consumer Healthcare Ltd(Merged) show a 25.93% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to GlaxoSmithkline Consumer Healthcare Ltd(Merged)'s most recent financial filings, the company has a total asset value of ₹5410.01, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a GlaxoSmithkline Consumer Healthcare Ltd(Merged) stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. GlaxoSmithkline Consumer Healthcare Ltd(Merged)'s 52-week high and low as of 2024-09-19 are ₹10850 and ₹10310, respectively.